Home / Health / Quebec Woman Among First in Canada to Receive New Alzheimer’s Drug

Health

Quebec Woman Among First in Canada to Receive New Alzheimer’s Drug

January 23, 2026 12:13 pm

Quebec Woman Among First in Canada to Receive New Alzheimer’s Drug

A Quebec woman ‍is among the first in Canada to ‌receive lecanemab, a newly approved drug for early-stage alzheimer’s disease. This offers a ‌potential new avenue for slowing the progression of the debilitating condition, though access and funding remain important hurdles.

Also Read: Calorie-Burning Cells: New Discovery for Safer Weight Management | Scientists Explain

Dr. Helena Fischer - Editor, Health

Full Name: Dr. Helena Fischer Role: Editor, Health Category: Health Location: Berlin, Germany Education: MD, Charité – Universitätsmedizin Berlin Experience: 11+ years in medical journalism and internal medicine Expertise: Public health, infectious diseases, healthcare policy, medical innovation Awards: European Health Journalism Award 2023 Professional Affiliations: Member, European Association of Science Editors Languages: German (native), English (fluent), Spanish (conversational) Bio: Dr. Helena Fischer is a respected physician and health journalist with over a decade of experience in internal medicine and science communication. She holds an MD from Charité – Universitätsmedizin Berlin. Dr. Fischer is passionate about public health, medical innovation, and making complex medical topics accessible to all. As Editor of the Health section at World Today Journal, she is dedicated to providing readers with accurate, up-to-date health news and expert analysis.